Share Pantelis Sarafidis, MD, MSc, PhD - Integrating Non-Steroidal Mineralocorticoid Receptor Antagonists Early in the Course of Disease: Practical Strategies for Patients With Early-Stage CKD and T2D

Copy link

March 30, 2023

Pantelis Sarafidis, MD, MSc, PhD - Integrating Non-Steroidal Mineralocorticoid Receptor Antagonists Early in the Course of Disease: Practical Strategies for Patients With Early-Stage CKD and T2D

12 minutes

Please visit answersincme.com/PGS860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in nephrology discusses integrating non-steroidal mineralocorticoid receptor antagonists (MRAs) in the treatment of patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). Upon completion of this activity, participants should be better able to: Evaluate the clinical impact of the latest safety and efficacy data for novel non-steroidal MRAs in patients with CKD and T2D; Identify patients with CKD and T2D who might benefit from treatment with novel non-steroidal MRAs; and Formulate treatment plans for patients with CKD and T2D that incorporate the latest evidence and guideline updates for non-steroidal MRAs.

...more